Frontiers Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer's disease

Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer's disease

RU-505 prevented altered thrombosis and fibrinolysis in AD transgenic

Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer's disease

Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ–Fibrinogen Interaction and Aβ-Induced Contact System Activation

Anti Aβ Monoclonal Antibody Mab 6e10 (Covance), Bioz

Frontiers Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer's disease

Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance - ScienceDirect

Frontiers Identifying Vulnerable Brain Networks in Mouse Models of Genetic Risk Factors for Late Onset Alzheimer's Disease

Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors. - Abstract - Europe PMC

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia. - Abstract - Europe PMC

The Pathobiology of Vascular Dementia

Astrocytes in human central nervous system diseases: a frontier for new therapies

Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance - ScienceDirect

Frontiers Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors